Molecular Screening Services
This Contract notice is a call for competition and is separate to any tender opportunity. Its purpose is to inform the market of a tender opportunity. NHS Blood and Transplant are looking for a Managed Service provider to provide a fully integrated high throughput testing solution for an automated Nucleic Acid Amplification Testing (NAT) system which can detect HBV DNA, HIV-1 RNA, HIV-2 RNA, HCV RNA, HEV RNA in EDTA plasma from blood and non-blood (e.g. stem cell, tissue) donors including from deceased (non-heart b...
Buyer
NHS Blood and Transplant
Value
£9,500,000
Published
12 Jun 2023
Closes
31 Jul 2023
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Open
Category
Services
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33124110
Diagnostic systems
Lots
Lot default Molecular Screening Services
£9,500,000
This Contract notice is a call for competition and is separate to any tender opportunity. Its purpose is to inform the market of a tender opportunity. NHS Blood and Transplant are looking for a Managed Service provider to provide a fully integrated high throughput testing solution for an automated Nucleic Acid Amplification Testing (NAT) system which can det...
Delivery: United Kingdom
Documents
Unlock document linkOpportunity notice on Contracts Finder
12 Jun 2023
Opportunity notice on Contracts Finder
Tender notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.